eGFR(Epidermal growth factor receptor) < 50mL/min
AST(aspartate aminotransferase)/ALT(alanine aminotransaminase) >2.5 upper limit of normal
Pregnant or lactating women
Subject who the investigator deems inappropriate to participate in this study
Patients with a history of bladder cancer or patients with active bladder cancer
Patients with uninvestigated macroscopic hematuria
Patients with cardiac failure or a history of cardiac failure (New York Heart Association [NYHA] Stages 3 to 4)
Patients with genetic problems such as galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption, since this study drug contains lactose
